- Home
- CZFS vs CANF Comparison
CZFS vs CANF Comparison
Compare CZFS & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- CANF
- Stock Information
- Founded
- CZFS 1984
- CANF 1994
- Country
- CZFS United States
- CANF Israel
- Employees
- CZFS N/A
- CANF N/A
- Industry
- CZFS Major Banks
- CANF Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- CANF Health Care
- Exchange
- CZFS Nasdaq
- CANF Nasdaq
- Market Cap
- CZFS 275.0M
- CANF 9.6M
- IPO Year
- CZFS N/A
- CANF N/A
- Fundamental
- Price
- CZFS $54.86
- CANF $0.50
- Analyst Decision
- CZFS
- CANF Strong Buy
- Analyst Count
- CZFS 0
- CANF 2
- Target Price
- CZFS N/A
- CANF $14.50
- AVG Volume (30 Days)
- CZFS 8.7K
- CANF 295.2K
- Earning Date
- CZFS 10-30-2025
- CANF 11-27-2025
- Dividend Yield
- CZFS 3.61%
- CANF N/A
- EPS Growth
- CZFS 15.37
- CANF N/A
- EPS
- CZFS 6.58
- CANF N/A
- Revenue
- CZFS $104,184,000.00
- CANF $560,000.00
- Revenue This Year
- CZFS N/A
- CANF $461.72
- Revenue Next Year
- CZFS $5.45
- CANF N/A
- P/E Ratio
- CZFS $8.34
- CANF N/A
- Revenue Growth
- CZFS 6.11
- CANF N/A
- 52 Week Low
- CZFS $49.99
- CANF $0.47
- 52 Week High
- CZFS $75.40
- CANF $3.12
- Technical
- Relative Strength Index (RSI)
- CZFS 39.35
- CANF 31.18
- Support Level
- CZFS $52.70
- CANF $0.47
- Resistance Level
- CZFS $56.12
- CANF $0.55
- Average True Range (ATR)
- CZFS 1.81
- CANF 0.04
- MACD
- CZFS -0.48
- CANF -0.01
- Stochastic Oscillator
- CZFS 22.04
- CANF 19.46
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).